Navigation Links
Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
Date:7/11/2011

ies include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2010. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.Contacts:Media RelationsInvestor RelationsJean-Marc Podvin

Sebastien MartelTel: +33 (0) 1 53 77 46 46

Tel: +33 1 53 77 45 45E-mail: mr@sanofi.com

E-mail: ir@sanofi.com Jack CoxTel: 908-981-5280E-mail: jack.cox@sanofi.com
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
2. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
3. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
4. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
5. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
6. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
7. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
8. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
9. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
10. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
11. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 NVSSoft, a Dubai ... a "Cool Vendor" by top IT research firm Gartner in ... Gartner defines a "Cool Vendor" as a company that ... The report highlights that, "as innovation gains ground ... markets should look at local technologies and services, which may ...
(Date:5/6/2015)... DIEGO , May 6, 2015  MEI Pharma, Inc. ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the Bank of America Merrill Lynch ... 8:00 a.m. Pacific time from the Encore at the Wynn ... of the presentation can be accessed at www.meipharma.com . ...
(Date:5/6/2015)... May 6, 2015 Advanced wound ... What does the future hold for the advanced ... report shows you potential revenues to 2025, assessing data, ... 189 page report provides 115 tables, charts, and graphs ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology:UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 4MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... Ill., Nov. 8, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... 8, 2010 Reportlinker.com announces that a ... its catalogue: The Future ... leading companies, and opportunities for target expansion ... G-Protein-coupled receptors (GPCRs) constitute the largest ...
Cached Medicine Technology:Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 2Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 3Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 4Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 5Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 6Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 7Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 8The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 2The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 3The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 4The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 5
(Date:5/6/2015)... (PRWEB) May 06, 2015 Qushanna Doby (20) ... a nearby drug treatment center in Florida while under the ... May 4th. New surveillance tapes released by CBS4’s Peter D’Oench ... her baby. Doby’s child is around one year old. The ... and shivering outside was not named. The residents polled by ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Corporate ... behalf of MEBC, an Alliance Award for excellence ... during FOCUS 2015, JDA’s annual user conference which ... retail and wholesale distribution sectors. This award recognizes ... are receiving services that advance their supply chain ...
(Date:5/6/2015)... May 06, 2015 The Canton Group is ... for the 6th annual charity softball game. The event ... & T Bank Stadium. Past years guests include Joe Flacco, ... are still on sale if you are interested ... local non-profit organizations, such as SOAR Baltimore and ...
(Date:5/6/2015)... Fla. (PRWEB) May 06, 2015 ... Institute are the first in north Florida and ... technology is the latest innovation in total hip ... highly advanced, surgeon-controlled robotic arm that enables the ... Medical Center Jacksonville has offered MAKOplasty® partial knee ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... go before they can claim to be new generation daddies, for only ... to a survey. ,The UK survey noted that 75 ... and 16 percent men argue every time over the issue. ... men argue about the job, it might help the couple to grow ...
... (RA) face different treatment options and determining which ones ... examined patients decisions regarding therapy for RA and glucosamine ... reluctant to change their treatment as long as their ... clinical trial results for glucosamine. ,Recent advances ...
... ability to walk. He and his mother feared that within ... a wheelchair. ,As is the case with more ... with few options and his family turned to Hospital for ... address his condition. ,They were introduced to David ...
... N.J., The European Commission granted marketing authorization ... atypical antipsychotic medication for the treatment ... designed to deliver paliperidone - the active ... osmotic delivery system (OROS(R)). ,In ...
... how gender affects learning have found that boys and ... different ways. ,However, they have suggested ... their kids from co-educational to segregated schools, or vice-versa. ... at Newcastle University in NSW, said that the key ...
... Scientists have achieved the first success in "decrypting" an enzyme's ... efficient route to drug discovery. ,Led by ... of Medicine, and Frank Raushel of Texas A and M, ... drug discovery, as many of the most successful drugs work ...
Cached Medicine News:Health News:Alternative Treatments for Arthritis 2Health News:Alternative Treatments for Arthritis 3Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 2Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 3Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 2Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 3Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:"Decryption" of Enzyme's Functions Paves Way for Future Drug Discovery 2
... and powerful Parisian Peel ESPRIT system encompasses ... for simplified skin care practice. , The ... meet strict medical device standards while offering ... a compact design. The ESPRIT offers ...
... high resolution optical coherence tonometry (OCT) retina ... It is based on the ... emerging from clinical research in the last ... and high resolution features enable the FD-OCT ...
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
The Clearview hCG Test is for the rapid detection of human chorionic gonadotropin (hCG) in urine specimens. This test kit is used to obtain a visual, qualitative result and is intended for professio...
Medicine Products: